🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Five-year OS update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC Journal of Hepatology doi.org/10.1016/j.jhep… 👉OS rate at 5 yrs: 19.6% vs 9.4% 🧐Interesting OS data for pts w/ disease control & any degree of tumour shrinkage ESMO - Eur. Oncology EASL Education ILCA

At Mayo Clinic Florida, our Interventional Radiology team runs an active clinic four days a week — offering expert consultations, pre-procedure planning, and dedicated follow-up care. We’re committed to providing patient-centered, collaborative care that supports each

MERITS-LT: Downstaging hepatocellular carcinoma patients outside of UNOS-DS criteria (aka "all comers" or AC) results in similar post-transplant survival to those within criteria (3-year 91% vs 81%, P = .67). 🏆 pmc.ncbi.nlm.nih.gov/articles/PMC10… What is your MDT using most commonly to

🌍 Today is #WorldLiverDay. The liver is responsible for over 500 vital functions in the body. From detoxifying harmful substances to breaking down the nutrients of the foods you eat, the liver acts as the filter for the whole body. MASLD is a buildup of fat in the liver that...

Today is #WorldLiverDay! Your liver works hard every day to keep you healthy—so let’s return the favor. #FoodIsMedicine for your liver, helping prevent disease and support overall well-being. World Liver Day

92% of responders chose #Y90 as the most commonly utilized Hepatocellular Carcinoma downstaging modality. This is consistent with reported national data: pubmed.ncbi.nlm.nih.gov/39522866/ 🔎 What makes this therapy effective for patients outside of Milan Criteria? ✅ More durable than

There is absolutely no reason that physicians should not be able to own hospitals. Period.

In 1929, a 25-year-old doctor cut into his own arm and inserted a catheter into his heart. No permission, no supervision, just sheer defiance. He risked death to prove a theory no one believed. His insane gamble saved millions of lives. Here's his story:

We're grateful to have our poster featured at #IVCMiami and honored that it was selected for an oral presentation. It was a great opportunity to share our work and learn from all the incredible research happening across the field. #IVC2025 #ResearchCommunity #Collaboration

Update: ...This study from our team was beautifully presented by Dr. Zlatko Devcic, —and we are excited to share that we won the Best Presentation Award! Truly grateful for the opportunity, the incredible teamwork, and for Dr. Devcic's outstanding representation of our work.

Resident IO knowledge is ahead of where current attendings were at that stage in training. This is how we advance. 🧩

🧠 ⚡ What you should know about intermediate stage HCC and combining local therapy plus immunotherapy. 🧩 Was a real pleasure to work with my friend and colleague Ruth He, MD, PhD and the awesome CORE2ED team.

Pts with intermediate stage #HCC may benefit from multimodal strategies, combining IO with locoregional therapies ➡️Get an expert overview of the expanding role of IO in HCC in this new micro learning! Register here to see the resources & test your knowledge

Check out my niece Dallena Shelton's hand-drawn and animated video on #skeletal #muscle #biochemistry! 🧬💪🏻 Proud IR uncle. More please! 🤩

Machines should be developed for what humans cannot do, not to replace what is uniquely human. 🧩

#GEST2025 was fantastic. No better mix of Data+Details in #IRad. Congrats Jafar Golzarian, MD FSIR and GEST -Global Embolization Symposium & Technologies 👊🏻

Downstaging is the next paradigm for #Y90. 🧩

The inaugural Y90 session at #JSIR2025 is a wrap! 🗾

ありがとうございました! #JSIR2025

Awesome SIO and Society for Immunotherapy of Cancer collaboration! 🧩